Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Hepatology

• Publication date

  2009-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.22868PMID 19434741PMCID PMC2692572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of symptomatic gastroesophageal reflux disease on quality of life of patients with chronic liver disease

  2008cited by this paper
• Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation.

  2008cited by this paper
• The Epidemiology of Newly Diagnosed Chronic Liver Disease in Gastroenterology Practices in the United States: Results From Population-Based Surveillance

  2008cited by this paper
• Fatigue as a major predictor of quality of life in women with autoimmune liver disease: the case of primary biliary cirrhosis.

  2008cited by this paper
• Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance

  2008cited by this paper
• Health‐related quality of life in chronic hepatitis B patients

  2008cited by this paper
• Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy.

  2007cited by this paper
• Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.

  2007cited by this paper
• Health‐related quality of life in patients with non‐alcoholic fatty liver disease

  2007cited by this paper
• Factors influencing change in health‐related quality of life after liver transplantation

  2007cited by this paper
• The Prevalence and Predictors of Elevated Serum Aminotransferase Activity in the United States in 1999–2002

  2006cited by this paper
• Determinants of quality of life in chronic liver patients

  2006cited by this paper
• Gastrointestinal symptoms in patients with liver cirrhosis: Associations with nutritional status and health-related quality of life

  2006cited by this paper
• Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania.

  2006cited by this paper
• Depression, Anxiety, and Nonalcoholic Steatohepatitis

  2006cited by this paper
• Increased cholinergic contractions of jejunal smooth muscle caused by a high cholesterol diet are prevented by the 5-HT4 agonist – tegaserod

  2006cited by this paper
• The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults

  2006cited by this paper
• Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: the veterans arthritis quality of life study.

  2005cited by this paper
• Estimating Utility Values for Health States of Overweight and Obese Individuals Using the SF-36

  2005cited by this paper
• Physical and Psychosocial Contributors to Quality of Life in Veterans With Hepatitis C Not on Antiviral Therapy

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Clinical significance of patient-reported questionnaire data: another step toward consensus.

  2005cited by this paper
• A new insight into the differences among non-cirrhotic and cirrhotic patients using the liver disease quality of life instrument (LDQOL).

  2005cited by this paper
• Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment

  2005cited by this paper
• Evaluation of Fatigue in U.S. Patients with Primary Biliary Cirrhosis

  2005cited by this paper
• Quality of life in patients with primary biliary cirrhosis

  2004cited by this paper
• Determinants of health-related quality of life in patients with chronic liver diseases.

  2004cited by this paper
• Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

  2004cited by this paper
• Health-State Utilities and Quality of Life in Hepatitis C Patients

  2003cited by this paper
• The prevalence and etiology of elevated aminotransferase levels in the United States

  2003cited by this paper
• Nonalcoholic steatohepatitis clinical research network

  2003cited by this paper
• Quality of life and cognitive function in hepatitis C at different stages of liver disease.

  2003cited by this paper
• Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

  2003cited by this paper
• Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study

  2003cited by this paper
• Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

  2003cited by this paper
• Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases.

  2002cited by this paper
• Burden of liver disease in the United States: Summary of a workshop

  2002cited by this paper
• American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease.

  2002cited by this paper
• Factors associated with poor health-related quality of life of patients with cirrhosis.

  2001cited by this paper
• Assessment of utilities and health-related quality of life in patients with chronic liver disease

  2001cited by this paper
• American Gastroenterological Association. Our new president--Jon I. Isenberg, M.D.

  2001cited by this paper
• Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C

  2001cited by this paper
• Health-related quality of life in chronic liver disease: the impact of type and severity of disease

  2001cited by this paper
• Cholestatic liver diseases and health-related quality of life

  2000cited by this paper
• Impact of obesity on health-related quality of life in patients with chronic illness

  2000cited by this paper
• Obesity and physical and emotional well-being: associations between body mass index, chronic illness, and the physical and mental components of the SF-36 questionnaire.

  2000cited by this paper
• Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease

  1999cited by this paper
• Quality-of-life assessments and chronic liver disease

  1998cited by this paper
• Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

  1998cited by this paper
• Health-related quality of life in obese persons seeking treatment.

  1996cited by this paper
• Effect of orthotopic liver transplantation on employment and health status.

  1996cited by this paper
• Interpretation of quality of life changes

  1993cited by this paper
• Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

  1990cited by this paper

• Unmet needs in hepatology: The guidance of the Italian association for the study of the liver (AISF).

  2026cites this paper
• Status and factors influencing health-related quality of life in patients with non-alcoholic fatty liver disease in Hangzhou: a cross-sectional study

  2025cites this paper
• Value-Based Pricing of Resmetirom for Metabolic Dysfunction–Associated Steatotic Liver Disease

  2025cites this paper
• Psychosocial risks in metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• Effects of combined prebiotic fiber supplementation and weight loss counseling in adults with metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial

  2025cites this paper
• Cost-effectiveness analysis of duodenal–jejunal bypass sleeve device for people with obesity

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease in adults

  2025cites this paper
• Late-Life Metabolic Dysfunction-Associated Steatotic Liver Disease and its Association With Physical Disability and Dementia

  2024cites this paper
• Review and expert opinion on MAFLD, oxidative stress and multifunctional management

  2024cites this paper
• Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment

  2024cites this paper
• Nonalcoholic fatty liver disease and female sexual dysfunction in Egyptian premenopausal women: is there a link between metabolic syndrome and sexual function?

  2024cites this paper
• Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cites this paper
• The impact of time-restricted eating on health-related quality of life: a systematic literature review

  2024cites this paper
• Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom

  2024cites this paper
• Association of the habitual dietary intake with the fatty liver index and effect modification by metabotypes in the population-based KORA-Fit study

  2024cites this paper
• Implementation of a randomized mobile-technology lifestyle program in individuals with nonalcoholic fatty liver disease

  2024cites this paper
• Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease.

  2023cites this paper
• Association between the severity of liver cirrhosis with quality of life and its impact on clinical practice

  2023cites this paper
• Steatotic liver disease is the most important somatic determinant of quality of life in patients with obesity: A cross‐sectional study

  2023cites this paper
• Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH

  2023cites this paper
• Health-related quality of life and its determinants among South Indian type 2 diabetes patients with and without non-alcoholic fatty liver disease

  2023cites this paper
• Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective

  2023cites this paper
• The metabolic associated fatty liver disease responses of lifestyle changes using diet and exercise

  2023cites this paper
• Novel Noninvasive Paraclinical Study Method for Investigation of Liver Diseases

  2023cites this paper
• The effects of medicinal and food homologous substances on blood lipid and blood glucose levels and liver function in patients with nonalcoholic fatty liver disease: a systematic review of randomized controlled trials

  2023cites this paper
• Improved health‐related quality of life with semaglutide in people with non‐alcoholic steatohepatitis: A randomised trial

  2023cites this paper
• The burden of nonalcoholic steatohepatitis (NASH) in the United States

  2023cites this paper
• Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus

  2023cites this paper
• Itemization difference of patient-reported outcome in patients with chronic liver disease

  2022cites this paper
• Impairment of patient‐reported outcomes among patients with non‐alcoholic fatty liver disease: a registry‐based study

  2022cites this paper
• Association between polypharmacy, patient-reported symptoms, and quality of life among nonalcoholic fatty liver disease patients in the United States

  2022cites this paper
• The Relationship between Health-Related Fitness and Quality of Life in Nonalcoholic Fatty Liver Disease

  2022cites this paper
• Geographical similarity and differences in the burden and genetic predisposition of NAFLD

  2022cites this paper
• Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV

  2022cites this paper
• Association between hepatic steatosis and fibrosis indices and dietary habits, physical activity, and quality of life.

  2022cites this paper
• Association of changes in histologic severity of nonalcoholic steatohepatitis and changes in patient‐reported quality of life

  2022cites this paper
• Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease

  2022cites this paper
• The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes

  2022cites this paper
• The contribution of daytime sleepiness to impaired quality of life in NAFLD in an ethnically diverse population

  2022cites this paper
• The effect of polypharmacy on quality of life in adult patients with nonalcoholic fatty liver disease in the United States

  2022cites this paper
• Advancing the global public health agenda for NAFLD: a consensus statement

  2021cites this paper
• Effect of Fermented Rice Drink “Amazake” on Patients with Nonalcoholic Fatty Liver Disease and Periodontal Disease: A Pilot Study

  2021cites this paper
• Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review

  2021cites this paper
• Mass Spectrometry-Based Proteomics in Alcoholic and Non-Alcoholic Steatohepatitis

  2021cites this paper
• Safety and Effectiveness of Essential Phospholipids Paste in Patients with Non-alcoholic Fatty Liver Disease or Viral Hepatitis.

  2021cites this paper
• Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey

  2021cites this paper
• Review of Clinical Guidelines in the Diagnosis of Pediatric Nonalcoholic Fatty Liver Disease

  2021cites this paper
• Impact of standard treatment on the quality of life of non-alcoholic fatty liver disease patients

  2021influential citation
• Hepatic Fat Reduction Due to Resmetirom in Patients with Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life.

  2021cites this paper
• Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities

  2021cites this paper
• Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention

  2021cites this paper
• Health-related quality of life in Chinese population with non-alcoholic fatty liver disease: a national multicenter survey

  2021cites this paper
• Quality of Life in patients with nonalcoholic fatty liver disease: Structure and related factors focusing on illness uncertainty.

  2021cites this paper
• Perception of Illness and Its Association with Treatment Willingness in Patients with Newly Diagnosed Nonalcoholic Fatty Liver Disease

  2021cites this paper
• Steatosis, Steatohepatitis and Related Conditions

  2021cites this paper
• Omega-3 derivatives, specialized pro-resolving mediators: Promising therapeutic tools for the treatment of pain in chronic liver disease.

  2020cites this paper
• Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study

  2020cites this paper
• (13C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle

  2020cites this paper
• Psychological Biomarker Profile in NAFLD/NASH with Advanced Fibrosis

  2020cites this paper
• Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease

  2020cites this paper
• Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis

  2020cites this paper
• An Algorithmic Approach to NAFLD Screening: From PCP to Specialist

  2020cites this paper
• Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease

  2020cites this paper
• Real-World Burden of Nonalcoholic Steatohepatitis.

  2020cites this paper
• The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

  2020cites this paper
• Burden of Disease due to Nonalcoholic Fatty Liver Disease.

  2020cites this paper
• Association between Non-Alcoholic Fatty Liver Disease and Dietary Habits, Stress, and Health-Related Quality of Life in Korean Adults

  2020cites this paper
• Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis.

  2020influential citation
• Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements

  2020cites this paper
• Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis

  2020cites this paper
• The Impact of Non-alcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective.

  2020cites this paper
• Safety and Patient-Reported Outcomes in Non-Alcoholic FattyLiver Disease and Viral Hepatitis Patients Taking EssentialPhospholipids Paste as Adjunctive Treatment

  2020cites this paper
• Decreased Quality of Life is Significantly Associated with Body Composition in Patients with Nonalcoholic Fatty Liver Disease.

  2020cites this paper
• Health-related Quality of Life in Non-alcoholic Fatty Liver Disease Associates With Hepatic Inflammation.

  2019cites this paper
• The frequency, clinical course, and health related quality of life in adults with Gilbert’s syndrome: a longitudinal study

  2019cites this paper
• Population Management of Nonalcoholic Fatty Liver Disease.

  2019cites this paper
• The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs

  2019cites this paper
• PROs of Patient-reported Outcomes for Nonalcoholic Fatty Liver Disease and Effects on Treatment for Nonalcoholic Steatohepatitis.

  2019cites this paper
• Liver-related complications and metabolic comorbidities during long-term follow-up of patients with Non-Alcoholic Fatty Liver Disease

  2019cites this paper
• A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH)

  2019cites this paper
• The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study

  2019cites this paper
• The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A real-world patient-reported outcomes study

  2019cites this paper
• With the enormous burden of NAFLD on the rise , quality care for patients warrants resource-adaptive population health management strategies

  2019cites this paper
• Deep learning enables pathologist-like scoring of NASH models

  2019cites this paper
• A Review of the Clinical Trials of Traditional Chinese Medicine in the Treatment of Nonalcoholic Fatty Liver Disease in Recent Ten Years

  2019cites this paper
• Metabolic Syndrome Is Associated with Health-Related Quality of Life in Suspected Patients with Nonalcoholic Steatohepatitis

  2018cites this paper
• Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review

  2018influential citation
• POSITION STATEMENT 1 The Belgian Association for Study of the Liver Guidance Document on the Management of Adult and Paediatric Non-Alcoholic Fatty Liver Disease

  2018cites this paper
• Quality of life in patients with nonalcoholic fatty liver disease: A systematic review.

  2018influential citation
• Quality of Life in Patients with Cirrhosis—Measurement and Clinical Impact

  2018cites this paper
• Effects of extracts from soothing-liver and invigorating-spleen formulas on the injury induced by oxidative stress in the hepatocytes of rats with non-alcoholic fatty liver disease induced by high-fat diet

  2018cites this paper
• Health-related quality of life in liver cirrhosis patients using SF-36 and CLDQ questionnaires

  2018cites this paper
• Direct and Indirect Economic Burden of Chronic Liver Disease in the United States

  2017cites this paper
• A disease‐specific quality of life instrument for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: CLDQ‐NAFLD

  2017cites this paper
• Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women

  2017cites this paper
• Exosomal miRNAs as biomarkers in the diagnosis of liver disease.

  2017cites this paper
• HRQOL using SF36 (generic specific) in liver cirrhosis

  2017cites this paper
• Primary non‐function is frequently associated with fatty liver allografts and high mortality after re‐transplantation

  2017cites this paper
• Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy

  2017cites this paper
• Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost‐effectiveness analysis

  2017cites this paper